Hepatocellular Carcinoma Surveillance: An Effective But Complex Process

被引:0
|
作者
Singal, Amit G. [1 ,2 ]
Murphy, Caitlin C. [1 ,2 ]
机构
[1] UT Southwestern Med Ctr, Div Digest & Liver Dis, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA
关键词
D O I
10.1053/j.gastro.2018.08.066
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1215 / 1215
页数:1
相关论文
共 50 条
  • [1] Hepatocellular carcinoma: is surveillance cost effective?
    Bruix, J
    Llovet, JM
    GUT, 2001, 48 (02) : 149 - 150
  • [2] Failure Rates in the Hepatocellular Carcinoma Surveillance Process
    Singal, Amit G.
    Yopp, Adam C.
    Gupta, Samir
    Skinner, Celette Sugg
    Halm, Ethan A.
    Okolo, Eucharia
    Nehra, Mahendra
    Lee, William M.
    Marrero, Jorge A.
    Tiro, Jasmin A.
    CANCER PREVENTION RESEARCH, 2012, 5 (09) : 1124 - 1130
  • [3] Surveillance for hepatocellular carcinoma in cirrhosis is cost-effective.
    Farinati, F
    Rinaldi, M
    Vian, A
    Gianni, S
    Chiaramonte, M
    Naccarato, R
    HEPATOLOGY, 1998, 28 (04) : 245A - 245A
  • [4] Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?
    Farinati, F
    Gianni, S
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (01) : 111 - 115
  • [5] PROCESS OF CARE FAILURE RATES FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE
    Singal, Amit G.
    Yopp, Adam C.
    Tiro, Jasmin A.
    Skinner, Celette S.
    Packer, Milton
    Nehra, Mahendra
    Lee, William M.
    Marrero, Jorge A.
    HEPATOLOGY, 2011, 54 : 408A - 409A
  • [6] HEPATOCELLULAR CARCINOMA SURVEILLANCE PROCESS FAILURES IN PATIENTS WITH CIRRHOSIS
    Marquardt, Patrick C.
    Liu, Po-Hong
    Immergluck, Joshua
    Rich, Nicole E.
    Yopp, Adam
    Odewole, Mobolaji
    Singal, Amit G.
    GASTROENTEROLOGY, 2020, 158 (06) : S1295 - S1295
  • [7] Is hepatocellular carcinoma surveillance in high-risk populations effective?
    Onyirioha, Kristeen
    Mittal, Sukul
    Singal, Amit G.
    HEPATIC ONCOLOGY, 2020, 7 (03)
  • [8] Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options?
    Zapata, E.
    Zubiaurre, L.
    Castiella, A.
    Salvador, P.
    Garcia Bengoechea, M.
    Esandi, P.
    Arriola, A.
    Beguiristain, A.
    Ruiz, I.
    Garmendia, G.
    Orcolaga, R.
    Alustiza, J. M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (08) : 484 - 488
  • [10] Surveillance for hepatocellular carcinoma
    Sherman, M
    SEMINARS IN ONCOLOGY, 2001, 28 (05) : 450 - 459